Trial Profile
The efficacy and safety of pyridoxamine in patients with autism spectrum disorder; Exploratory physician-led Phase II trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2021
Price :
$35
*
At a glance
- Drugs Pyridoxamine (Primary) ; Thiamine
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 21 Jul 2021 Status changed from active, no longer recruiting to completed.
- 16 Sep 2020 Planned End Date changed from 31 Mar 2020 to 31 Dec 2020.
- 16 Sep 2020 Planned number of patients changed from 72 to 78.